N-Benzyl carbamate Sitagliptin
CAS No. | : NA |
Mol F. | : C24H19F6N5O4 |
Mol W. | : 555.43 |
Cat No. | : SA10430 |
- Description
- Quick Enquiry / RFQ
Description
Product Name | N-Benzyl carbamate Sitagliptin |
Synonyms | (R)-benzyl 4-oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-ylcarbamate
Benzyl (4-Oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate |
Related API | Sitagliptin |
Category | Impurities |
N-Benzyl carbamate Sitagliptin product with CAS: NA is also known as (R)-benzyl 4-oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-ylcarbamate. This product can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. N-Benzyl carbamate Sitagliptin is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Sitagliptin and its related formulations. Moreover, (R)-benzyl 4-oxo-4-(8-oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-ylcarbamate is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]